PlainRecalls
FDA Drug Low Class III Terminated

Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.

Reported: August 19, 2020 Initiated: July 20, 2020 #D-1496-2020

Product Description

Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.

Reason for Recall

Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.

Details

Units Affected
7632 tubes
Distribution
Nationwide in the U.S.
Location
Hawthorne, NY

Frequently Asked Questions

What product was recalled?
Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.. Recalled by Taro Pharmaceuticals U.S.A., Inc.. Units affected: 7632 tubes.
Why was this product recalled?
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 19, 2020. Severity: Low. Recall number: D-1496-2020.